Bill > SRes477

This resolution designates the first full week in May as "Tardive Dyskinesia Awareness Week" and highlights the critical importance of understanding and addressing tardive dyskinesia (TD), a neurological condition characterized by involuntary, repetitive movements that can occur as a side effect of long-term antipsychotic medication use. The resolution acknowledges that approximately 800,000 adults in the United States live with TD, with about 60 percent remaining undiagnosed, and emphasizes the condition's potential to significantly impact individuals' physical, social, and emotional well-being. It recognizes that people over 55, Black individuals, women, and those with mood or substance use disorders are at higher risk, and underscores the American Psychiatric Association's recommendation for routine TD screening. By establishing this awareness week, the Senate aims to encourage education about TD screening for healthcare providers, patients, and caregivers, promote understanding of the condition's causes and symptoms, and support early detection and intervention strategies to improve outcomes for individuals prescribed antipsychotic medications.

Justice

https://www.congress.gov/bill/119th-congress/senate-resolution/477/all-info